AOC Slams Big Pharma Over Drug Patents, Says Humira Case Kept Prices High

Representative Alexandria Ocasio-Cortez (AOC) criticized major pharmaceutical companies during a House health subcommittee hearing, accusing them of using the U.S. patent system to delay cheaper generic medicines and keep prescription drug prices high. Using AbbVie's blockbuster arthritis drug Humira as an example, AOC argued that the company secured more than 130 patents related to the medicine, extending its market exclusivity. She also cited an AstraZeneca inhaler, saying minor design changes were used to obtain additional patents without altering the medicine itself. Supporters of patent reform say these practices delay generic and biosimilar competition, while pharmaceutical companies argue that follow-on patents can reflect meaningful improvements in safety, drug delivery, and patient use. Watch the key moments from the hearing. #AOC #AlexandriaOcasioCortez #BigPharma #Humira #DrugPrices #Healthcare #USPolitics #PrescriptionDrugs #PatentReform #Congress #BreakingNews #Health Moneycontrol is India’s leading financial portal, offering market news, expert analysis, and powerful tools. A part of Network18, moneycontrol.com is India’s most trusted destination for financial and business news. #live #livenews #latestnews #topnews #moneycontrol #moneycontrollive #businessnews #businessnewslive #stockmarket #stockmarket #sharemarketnews #stockmarketliveupdates Subscribe: https://bit.ly/moneycontrolyoutube Follow us: Visit https://www.moneycontrol.com/ Facebook: /moneycontrol Twitter: /moneycontrolcom Instagram: /moneycontrolcom